A phase I trial of afatinib (Afa) and bevacizumab (Bev) in chemo-naïve patients (pts) with advanced non-small-cell lung cancer (NSCLC) harboring EGFR-mutations: OLCSG1404

Saved in:

Bibliographic Details
Published in	Annals of oncology Vol. 28; pp. x129 - x130
Main Authors	Harada, D., Nogami, N., Kozuki, T., Ninomiya, T., Bessho, A., Kuyama, S., Fujimoto, N., Sugimoto, K., Aoe, K., Ochi, N., Minami, D., Fukamatsu, N., Kudo, K., Kiura, K.
Format	Journal Article
Language	English
Published	Elsevier Ltd 01.11.2017
Online Access	Get full text

Loading…

More Information
ISSN:	0923-7534 1569-8041
DOI:	10.1093/annonc/mdx671.015